Myomo (MYO) Operating Margin (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,270.00 |
| Jun 30, 2025 | -1,175.00 |
| Mar 31, 2025 | -3,377.00 |
| Dec 31, 2024 | 837.00 |
| Sep 30, 2024 | 443.00 |
| Jun 30, 2024 | 8,875.00 |
| Mar 31, 2024 | -5,242.00 |
| Dec 31, 2023 | -1,130.00 |
| Sep 30, 2023 | -2,134.00 |
| Jun 30, 2023 | 5,898.00 |
| Mar 31, 2023 | -2,233.00 |
| Dec 31, 2022 | 1,587.00 |
| Sep 30, 2022 | 771.00 |
| Jun 30, 2022 | -794.00 |
| Mar 31, 2022 | -369.00 |
| Dec 31, 2021 | -2,080.00 |
| Sep 30, 2021 | 3,743.00 |
| Jun 30, 2021 | 4,176.00 |
| Mar 31, 2021 | -8,100.00 |
| Dec 31, 2020 | 8,760.00 |
| Sep 30, 2020 | 19,967.00 |
| Jun 30, 2020 | 771.00 |
| Mar 31, 2020 | -16,976.00 |
| Dec 31, 2019 | 29,599.00 |
| Sep 30, 2019 | -15,829.00 |
| Jun 30, 2019 | 1,579.00 |
| Mar 31, 2019 | -1,575.00 |
| Dec 31, 2018 | 13,729.00 |
| Sep 30, 2018 | -2,062.00 |
| Jun 30, 2018 | 34,313.00 |
| Mar 31, 2018 | 157,175.00 |
| Dec 31, 2017 | -204,529.00 |
| Sep 30, 2017 | 33,671.00 |
| Jun 30, 2017 | 674,086.00 |
| Mar 31, 2017 | -712,648.00 |
| Dec 31, 2016 | 26,216.00 |
| Sep 30, 2016 | -23,596.00 |